Actinium Pharmaceuticals ATNM
NYSE ATNM
$1.15 +0.00 (+0.00%)
As of: Oct 2, 2026 · 2:51 PM EDT

Actinium Pharmaceuticals (ATNM) Depreciation & Amortization (CF) (2012 - 2026)

Updated

Actinium Pharmaceuticals' Depreciation & Amortization (CF) was $432,000 in Q2 2026, up 19.3% from $362,000 a year earlier.

Analysis

Actinium Pharmaceuticals (ATNM) Depreciation & Amortization (CF) (2012 - 2026) Analysis & Trends

On a trailing twelve-month basis, Actinium Pharmaceuticals' Depreciation & Amortization (CF) was $225,000 through Jun 30, 2026, up 11.9% year-over-year; for FY2025, it came in at $173,000, down 12.2% from FY2024.

  • Depreciation & Amortization (CF) has now declined for three consecutive years, with a five-year compound annual growth rate of -17.3% (FY2020 to FY2025).
  • In earlier years, Depreciation & Amortization (CF) was $197,000 in FY2024 (-4.8%), $207,000 in FY2023 (-70.4%), $699,000 in FY2022 (+33.4%) and $524,000 in FY2021 (+17.2%).
  • The Q2 2026 figure marks the highest quarterly Depreciation & Amortization (CF) in data going back to Q1 2012.
  • Compared with a year earlier, Depreciation & Amortization (CF) was higher in four of the last six quarters, with an average decline of 0.4%.
  • The best year-over-year quarter for Depreciation & Amortization (CF) over five years was Q2 2025 (growth of 91.5%); the worst was Q1 2025 (a decline of 78.2%).
  • Per Business Quant data, ATNM's Depreciation & Amortization (CF) in the three quarters before Q2 2026 was $29,000 (Q1 2026), -$442,000 (Q4 2025) and $206,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Actinium Pharmaceuticals 36.16 Mn 36.16 Mn - 432,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 432,000.00
Mar 31, 2026 29,000.00
Dec 31, 2025 -442,000.00
Sep 30, 2025 206,000.00
Jun 30, 2025 362,000.00
Mar 31, 2025 47,000.00
Dec 31, 2024 -410,000.00
Sep 30, 2024 202,000.00
Jun 30, 2024 189,000.00
Mar 31, 2024 216,000.00
Dec 31, 2023 -384,000.00
Sep 30, 2023 200,000.00
Jun 30, 2023 209,000.00
Mar 31, 2023 182,000.00
Dec 31, 2022 161,000.00
Sep 30, 2022 221,000.00
Jun 30, 2022 180,000.00
Mar 31, 2022 137,000.00
Dec 31, 2021 137,000.00
Sep 30, 2021 133,000.00
API Access

Actinium Pharmaceuticals Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=ATNM&period=max&api_key=YOUR_API_KEY